Navigation Links
Algeta Demonstrates Targeted Cancer-killing Potential of Novel,Alpha Particle Linked Antibodies in Leading Medical Journal Blood

p>Therapy with 227Th-rituximab was significantly more effective than the control radioimmunoconjugate 227Th-trastuzumab, which does not bind CD20, and the standard beta particle emitting radioimmunoconjugate for CD20-positive lymphoma, Zevalin® (90Y-tiuxetan-ibritumomab), which is marketed by Biogen-Idec.

Dr Thomas Ramdahl, President and CEO of Algeta commented: "This important paper provides more evidence of the potential of alpha particle based molecules for targeted cancer therapy. The publication follows excellent Phase II clinical data for our lead product Alpharadin (radium-223) in prostate cancer, which was published recently in the Lancet Oncology. We are working with collaborators to validate our TH-1 technology and are looking for further partnering opportunities with companies that have interesting cancer-targeting molecules that would benefit from this approach."

Reference

Targeted cancer therapy with a novel low dose rate alpha-emitting radioimmunoconjugate (2007) Dahle, J. et al. (2007)

http://bloodjournal.hematologylibrary.org/cgi/ content/abstract/blood-2007-01-066803v1

###

For further information, please contact

Dr. Thomas Ramdahl, CEO +47 23 00 79 90 / +47 913 91 458 (mob) Geir Christian Melen, CFO +47 23 00 79 90 / +47 913 02 965 (mob) post@algeta.com

Dr. Mark Swallow / Helena +44 (0)207 638 9571 Galilee mark.swallow@citigatedr.co.uk Citigate Dewe Rogerson

About Algeta

Algeta ASA (www.algeta.com) is a Norwegian cancer therapeutics company built on world-leading, proprietary technology.

Algeta is developing new, targeted cancer therapeutics that harness the unique characteristics of alpha particle emitters and are pote
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
2. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
3. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
4. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
5. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
6. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
7. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
8. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
9. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
10. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
11. Lpath Demonstrates First-in-Class AMD Results With Its Lead Drug Candidate, Sphingomab
Post Your Comments:
(Date:3/5/2015)... March 5, 2015 Soligenix, Inc. (OTCQB: SNGX) ... committed to developing products that address unmet medical needs ... today that its President and Chief Executive Officer, ... presentation at the 27 th Annual ROTH Conference ... Tuesday, March 10, 2015 at 1:00 PM Pacific Daylight ...
(Date:3/5/2015)... , March 5, 2015 ... new generation of OASIS *    at ECR ... processing power will set a benchmark for patient-centric care. ... and prevent delays whilst optimizing workflow management and costs. ... comfort and safety for imaging in Neurology, Orthopaedics, Paediatrics, ...
(Date:3/5/2015)... Denmark , March 5, 2015 ... that applies its innovative TransCon technology to address ... present two posters at the ENDO 2015 conference ... The posters will be presented on Thursday, March ... is being held from 1:00pm-3:00pm PST, and are ...
Breaking Medicine Technology:Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3Ascendis Pharma to Present at ENDO 2015 2
... for Regulatory Effectiveness reports that the President,s Budget ... for beneficiaries who use home oxygen and other ... the ability of Medicaid beneficiaries to remain in ... home medical care as a cost-saving alternative to ...
... BOSTON, Feb. 14, 2012   Solos Endoscopy, Inc. (OTCPK: ... has completed the retirement of one hundred fifty million ... in exchange for Series B Convertible Preferred Shares. The ... now been cancelled and returned back to the Company ...
Cached Medicine Technology:President's Budget Declares War on Medicaid Recipients 2Solos Endoscopy, Inc. Announces Retirement of 150 Million Common Shares 2
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market is expected ... 2014 to 2019. , The global digital PCR (dPCR) and qPCR ... 2014 to 2019. Although the mature markets such as the U.S., ... (dPCR) and qPCR market the Asia-Pacific region is expected to grow ... growth of the digital PCR (dPCR) and qPCR market is driven ...
(Date:3/5/2015)... 05, 2015 This week, ... in low-cost laminate flooring products, initiating widespread concern ... eco-friendly building materials made primarily from bamboo, stands ... all their flooring products for volatile organic compounds ... Benchmark International (BMH). Results from formaldehyde emissions ...
(Date:3/5/2015)... AxoGen, Inc. (NASDAQ: AXGN) , a leading ... market, reported record revenue of $4.79 million for the ... million in the year-ago fourth quarter demonstrating the Company’s ... strong fourth quarter revenue growth reflects the market’s growing ... driving increased surgeon adoption of our unique product portfolio ...
(Date:3/5/2015)... Testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ) filed ... strokes and other serious cardiovascular events due to their ... forward in the federal multidistrict litigation now underway in ... a Case Management Order issued on March 3rd, the ... master pleadings in the proceeding. Among other things, the ...
(Date:3/5/2015)... Rhode Island Medical Imaging (RIMI) was pleased to donate ... the Providence College (PC) women’s basketball program’s fight to end ... ‘Think Pink’ uniforms, which were worn during the February 22nd ... at Alumni Hall/Mullaney Gymnasium in Providence, R.I. , ... women’s basketball’s ‘Pink Out’ event,” said Dr. Scott Levine of ...
Breaking Medicine News(10 mins):Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2
... Feb. 25 MedCath Corporation,(Nasdaq: MDTH ) announced ... Raymond James 29th Annual Institutional Investors,Conference held March 2-5 ... MedCath,s senior management will give its presentation on Monday, ... web cast live over the Internet,via MedCath,s website ...
... donors to become the first in the country to benefit ... ... BIO-key International,Inc. (OTC Bulletin Board: BKYI), a leader in finger-based ... Blood Center is deploying BIO-key,s WEB-key(R) biometric,identification technology to enhance ...
... Could Save Millions Their Sight, PORTLAND, Ore., ... has only approved Avastin for cancer of the ... proving itself as a "miracle,drug" that,s currently used ... prostate, renal cell, head and neck, pancreatic, ovarian,and ...
... BOSTON, Feb. 25 Cell phones have become ... immediate and often,location independent. Connecting can be intimate ... more visually engaging with new MMS,(Multimedia Messaging Service) ... inspire, motivate or simply make someone smile., ...
... the first module, targeting ... ... the,Healthcare Information and Management Systems Society (HIMSS) 2008 Annual,Conference & Exhibition, ... a software-based solution designed to,help healthcare organizations identify potential adverse events ...
... Hospice Now Serves as HIV/AIDS Care Hub, LOS ... filing of a lawsuit against the City of Los ... of contract and for a,"judicial determination" regarding the validity ... US, largest non-profit HIV/AIDS,healthcare, research, prevention and education provider. ...
Cached Medicine News:Health News:Indiana Blood Center Signs BIO-key(R) Contract 2Health News:Indiana Blood Center Signs BIO-key(R) Contract 3Health News:Off-Label Avastin Use for Wet Macular Degeneration 2Health News:Off-Label Avastin Use for Wet Macular Degeneration 3Health News:Family, Friends and Support Groups Add Picture Messaging to Inspire and Motivate - Anywhere, Anytime 2Health News:Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In-Hospital Infections 2Health News:Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In-Hospital Infections 3Health News:Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In-Hospital Infections 4Health News:AHF Sues L.A. Housing Dept. to Prevent Closure of AIDS Site 2Health News:AHF Sues L.A. Housing Dept. to Prevent Closure of AIDS Site 3Health News:AHF Sues L.A. Housing Dept. to Prevent Closure of AIDS Site 4Health News:AHF Sues L.A. Housing Dept. to Prevent Closure of AIDS Site 5
200 L, Racked, Pre-sterilized, 96 tips/rack, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
MBP's 200 L large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
... The assay is an immunometric ... of LH in human serum or ... bound by 2 monoclonal anti-LH antibodies ... is attached to magnetic particles and ...
... (LH) is a glycoprotein secreted by the ... and TSH, the intact LH molecule is ... These glycoproteins all have homologous alpha-subunits, however ... LH and FSH production and secretion are ...
Medicine Products: